期刊文献+

利托君和沐舒坦治疗早产孕妇的疗效观察及护理 被引量:5

Observation of treatment effect of ritodrine and ambroxol in premature delivery patients and nursing
原文传递
导出
摘要 目的探讨利托君与沐舒坦用于早产孕妇以促进胎肺成熟、减少早产儿窒息的疗效及护理。方法将218例早产孕妇随机分为治疗组110例和对照组108例,治疗组采用利托君和沐舒坦治疗早产,对照组采用常规治疗方法,比较2组治疗效果。结果治疗组孕期延长平均天数、足月分娩率、新生儿出生体质量〉2500g的百分率、产妇产褥感染发生率、早产儿获得性肺炎发生率等指标均显著优于对照组。结论利托君用于治疗早产安全有效;对于〈34周的早产儿,产前应用沐舒坦可促进胎肺成熟,显著降低母婴并发症。 Objective To discuss treatment effect of ritodrine and ambroxol on acceleration of fetal lung maturation, reduction of asphyxia of premature infants in premature women, and nursing. Methods 218 pregnant woman with premature delivery were divided into the treatment group (110 cases) and the control group (108 cases)stochastically. The treatment group adopted ritodrine and ambroxol, the control group adopted routine method. The curative effect was compared between two groups. Results The prolonged pregnancy time, rate of term labor, rate of newborn body weight〉2500 g, incidence rate of puerperal infection, rate of neonatal pneumonia in the treatment group were better than those of the control group. Conclusions Appli-cation of ritodrine in treating premature delivery proved to be safe and effective. For premature infants 〈 34 weeks, prenatal use of ambroxol may promote the fetal lung maturity and reducecomplication rate of moth-ers and infants.
出处 《中国实用护理杂志》 北大核心 2012年第24期3-5,共3页 Chinese Journal of Practical Nursing
关键词 早产 利托君 沐舒坦 疗效 护理 Premature delivery Ritodrine Curative effect Nursing
  • 相关文献

参考文献5

二级参考文献23

  • 1朱宝馀,符玉良.苄羟麻黄碱治疗早产的临床观察[J].中华妇产科杂志,1996,31(12):721-723. 被引量:34
  • 2胡亚美 江载芳 陆华 申昆玲 左启华 李同 等.实用儿科学(第7版)[M].北京:人民卫生出版社,2002.698-705.
  • 3Lazzarin A,Capsoni F,Leurti M,et al.Immunological characteristics of preterm neonates after prophylaxis of NRDS.In:Bianali M,Cosmi EV,Luerti M,eds.Diagnosis and treatment of fetal lung immaturity.Milan:Masson,1986.134-139.
  • 4Wauer RR,Schmalisch G,Hammer H,et al.Ambroxol for prevention and treatment of hyaline membrane disease.Eur Respir J,1989,3(Supple 3):57s-65s.
  • 5Gibbs RS,Duff P.Progress in pathogenesis and management of clinical intraamniotic infection.Am J Obstet Gynecol,1991,164:1317-26.
  • 6Vermillion ST,Soper DE,Bland ML,et al.Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes.Am J Obstet Gynecol,2000,183:925-929.
  • 7Luerti M,Lazzarin A,Corbella E,et al.An alternative to steroids for prevention of respiratory distress symdrome (RDS):multicenter controlled study to compare ambroxol and betamethasone.J Perinat Med,1987,15:227-238.
  • 8Kimya Y,Kucukkomurcu S,Ozan H,et al.Antenatal ambroxol usage in the prevention of infant respiratory distress syndrome.Beneficial and adverse effects.Clin Exp Obstet Gynecol,1995,22:204-211.
  • 9Laoag Fernandez JB,Fernandez AM,Maruo T.Antenatal use of ambroxol for the prevention of infant respiratory distress syndrome.J Obstet Gynaecol Res,2000,26:307-312.
  • 10Heytmanek G,Salzer H,Vityska-Binstorfer E,et al.Ambroxol versus betamethasone for the promotion of antepartum lung maturity in pathological pregnancies.Wien Klin Wochenschr,1990,102:443-448.

共引文献21

同被引文献57

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部